2027 Future Talent Program - Global Lung Medical Affairs - Intern
MSD
Summary
The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. These opportunities in our Research Labs Division can provide you with great development and a chance to see if we are the right company for your long-term goals.
Job description
Collaborate with the Global Medical Affairs Lung team on key strategic projects:
- Support strategic and operational international congress planning and execution (e.g. ASCO, WCLC, ESMO). This will include communications and insights related to priority competitor and internal data readouts.
- Conduct scientific insights analyses using novel AI tools to identify and semi-quantify sentiment themes and translate these findings into actionable recommendations. Additionally, develop a methodology framework outlining how AI tools can be used to analyze scientific insights.
- Collaboration with GMSA Analytics Center of Excellence (ACE) team on global lung projects across V&I priorities.
Expected Gains:
- You will expand your capabilities and skills in strategic planning and execution of medical international congresses at the global level, in utilization of AI tools to analyze insights and in
- You will expand your network within the regional and global cross-functional parts of the organization.
Required Education:
- Full-time student pursuing a BS/BA, MS or PharmD/PhD.
Preferred Skills:
- Experience in analyzing medical insights and translating them into actionable outcomes and preferably also in utilization of AI tools (e.g. prompt building).
- Interest and background within science and pharmaceutical/medical field, oncology experience if available.
Requirements
- Full-time student pursuing a BS/BA, MS or PharmD/PhD.
Company overview
MSD, known as Merck Sharp & Dohme outside the United States and Canada, is a global research-intensive biopharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, the company has established itself as one of the world's leading pharmaceutical corporations with a rich history spanning over 130 years. MSD operates as the international division of Merck & Co., Inc., focusing on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, biologic therapies, and animal health products. The company's extensive portfolio includes groundbreaking treatments in oncology, infectious diseases, cardiology, diabetes, and vaccines, with notable products such as Keytruda (pembrolizumab) for cancer immunotherapy, Gardasil for HPV prevention, and Januvia for diabetes management. MSD maintains a strong commitment to research and development, investing significantly in scientific innovation to address unmet medical needs worldwide. With approximately 75,000 employees globally, the company operates through four main segments: pharmaceuticals, animal health, healthcare services, and strategic alliances. MSD's mission centers on using leading-edge science to save and improve lives around the world, guided by the principle that medicine is for people, not profits.